Urticaria unresponsive to antihistaminic treatment: An open study of therapeutic options based on histopathologic features

Journal of Dermatological Treatment

Volumn 19, Issue 2, 2008, Pages 92-96

  Criado, Roberta F J ^a   Criado, Paulo Ricardo ^b,d   Martins, Jośe Eduardo C ^b   Valente, Neusa Y S ^b   Michalany, Nilceo S ^c   Vasconcellos, Cidia ^b  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d NONE   (Brazil)

Author keywords

Antihistamines; Colchicines; Dapsone; Montelukast; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CLEMASTINE; COLCHICINE; DAPSONE; DESLORATADINE; EBASTINE; FEXOFENADINE; HYDROXYZINE; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; EOSINOPHIL; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; SKIN BIOPSY; URTICARIA;

ACETATES; ADULT; ANTI-INFECTIVE AGENTS; CHRONIC DISEASE; COLCHICINE; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; QUINOLINES; TUBULIN MODULATORS; URTICARIA;

EID: 45949111525     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701499309     Document Type: Article

References (22)

1. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CEH, Greaves MW, Henz BM, et al. EAACI/GA2LEN/EDF guideline: Definition, classification and diagnosis of urticaria. Allergy. 2006;61:316-20.
2. Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP. Histologic studies of chronic urticaria. J Allergy Clin Immunol. 1983;71:177-83.
3. Haas N, Toppe E, Henz BM. Microscopic morphology of different types of urticaria. Arch Dermatol. 1998;134:41-6.
4. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: Comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002;109:694-700.
5. Kitao A, Nobuhara S, Kore-Eda S, Takahashi K, Nishigori C, Miyachi Y. Persistent urticaria-urticarial reaction caused by late phase reaction? Eur J Dermatol. 2001;11:440-2.
6. Charlesworth EN. Urticaria and angioedema: A clinical spectrum. Ann Allergy Asthma Immunol. 1996;76:484-95.
7. Kitao A, Nishigori C, Miyachi Y. Late-phase urticaria Update. Curr Allergy Asthma Rep. 2002;2:288-91.
8. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, et al. EAACI/GA2LEN/EDF guideline: Management of urticaria. Allergy. 2006;61:321-31.
9. Toppe E, Haas N, Henz BM. Neutrophilic urticaria: Clinical features, histological changes and possible mechanisms. Br J Dermatol. 1998;138:248-53.
10. Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF. Pathophysiology of urticaria. Clin Rev Allergy Immunol. 2006;30:3-11.
11. Zuberbier T, Greaves MW, Juhlin L, Kobza-Black A, Maurer D, Stingl G, et al. Definition, classification, and routine diagnosis of urticaria: A consensus report. J Investig Dermatol Symp Proc. 2001;6:123-7.
12. Di Lorenzo G, Pacor ML,Mansueto P, Esposito-Pellitteri M, Ditta V, Lo Bianco C, et al. Is there a role for antileukotrienes in urticaria? Clin Exp Dermatol. 2006;31:327-34.
13. Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronicurticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol. 2004;113:134-40.
14. Goel A, Prasad D. Oral montelukast in urticaria induced by nonsteroidal anti-inflammatory drugs. J Eur Acad Dermatol Venereol. (2007). Published online: 25 May 2007. URL: http://www.blackwell-synergy.com/doi/full/10.1111/j.1468- 3083.2007.02168.x DOI: 10.1111/j.1468-3083.2007.02168.x.
15. Sanada S, Tanaka T, Kameyoshi Y, Hide M. The effectiveness of montelukast for the treatment of anti-histamine resistant chronic urticaria. Arch Dermatol Res. 2005;297:134-8.
16. Staumont-Salle D, Dombrowi CZD, Caproni M, Delaporte E. Eosinophils and urticaria. Clin Rev Allergy Immunol. 2006;30:13-18.
17. Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol. 2004;31:2429-32.
18. Sullivan TP, King LE Jr, Boyd AS. Colchicine in dermatology. J Am Acad Dermatol. 1998;39:993-9.
19. Oka T, Hori M, Ozaki H. Microtubule disruption suppresses allergic response through the inhibition of calcium influx in the mast cell degranulation pathway. J Immunol. 2005;174:4584-9.
20. Pfeiffer C, Wozel G. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol. 2001;45:420-34.
21. Boehm I, Bauer R, Bieber T. Urticaria treated with dapsone. Allergy. 1999;54:765-6.
22. Cassano N, D'Argento V, Filotico R, Vena GA. Low-dose dapsone in chronic idiopathic urticaria: Preliminary results of an open study. Acta Derm Venereol. 2005;85:254-5.